Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10907351 | Experimental Hematology | 2016 | 9 Pages |
Abstract
The retinoblastoma gene (RB1) has been implicated as a tumor suppressor in multiple myeloma (MM), yet its role remains unclear because in the majority of cases with 13q14 deletions, un-mutated RB1 remains expressed from the retained allele. To explore the role of Rb1 in MM, we examined the functional consequences of single- and double-copy Rb1 loss in germinal center B cells, the cells of origin of MM. We generated mice without Rb1 function in germinal center B cells by crossing Rb1Flox/Flox with C-γ-1-Cre (Cγ1) mice expressing the Cre recombinase in class-switched B cells in a p107â/â background to prevent p107 from compensating for Rb1 loss (Cγ1-Rb1F/F-p107â/â). All mice developed normally, but B cells with two copies of Rb1 deleted (Cγ1-Rb1F/F-p107â/â) exhibited increased proliferation and cell death compared with Cγ1-Rb1+/+-p107â/â controls ex vivo. In vivo, Cγ1-Rb1F/F-p107â/â mice had a lower percentage of splenic B220+ cells and reduced numbers of bone marrow antigen-specific secreting cells compared with control mice. Our data indicate that Rb1 loss induces both cell proliferation and death in germinal center B cells. Because no B-cell malignancies developed after 1 year of observation, our data also suggest that Rb1 loss is not sufficient to transform post-germinal center B cells and that additional, specific mutations are likely required to cooperate with Rb1 loss to induce malignant transformation.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Zhiwen He, Julie O'Neal, William C. Wilson, Nitin Mahajan, Jun Luo, Yinan Wang, Mack Y. Su, Lan Lu, James B. Skeath, Deepta Bhattacharya, Michael H. Tomasson,